Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
This study has been completed.
Study NCT00148148   Information provided by University Hospital Muenster
First Received: September 6, 2005   Last Updated: January 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fungus Diseases
Additional conditions recognized in this trial
Mycoses
Interventions listed in this trial
caspofungin
liposomal amphotericin B
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Hospital Muenster
MSD Sharp&Dohme, München
Gilead Sciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services